within Pharmacolibrary.Drugs.N_NervousSystem.N02C_AntimigrainePreparations.N02CD05_Eptinezumab;
model Eptinezumab 
   extends Pharmacolibrary.Drugs.ATC.N.N02CD05;

  annotation(Documentation(
    info ="<html><body><p>Eptinezumab is a humanized monoclonal antibody that targets calcitonin gene-related peptide (CGRP), which is involved in migraine pathophysiology. It is used as a preventive treatment for migraine in adults and is approved for clinical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters obtained from adult healthy volunteers and patients with migraine.</p><h4>References</h4><ol><li><p>Li, XN, et al., &amp; Larsen, F (2023). Pharmacokinetics and Safety of Eptinezumab in Healthy Chinese Participants: A Randomized Clinical Trial. <i>Clinical drug investigation</i> 43(11) 873–881. DOI:<a href=&quot;https://doi.org/10.1007/s40261-023-01315-1&quot;>10.1007/s40261-023-01315-1</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37917246/&quot;>https://pubmed.ncbi.nlm.nih.gov/37917246</a></p></li><li><p>Hershey, AD, et al., &amp; Rosen, M (2025). Pharmacokinetics and safety of eptinezumab in children and adolescents with migraine. <i>Headache</i> None –. DOI:<a href=&quot;https://doi.org/10.1111/head.14959&quot;>10.1111/head.14959</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/40444655/&quot;>https://pubmed.ncbi.nlm.nih.gov/40444655</a></p></li><li><p>Smith, TR, et al., &amp; Schaeffler, B (2020). Eptinezumab for the Prevention of Episodic Migraine: Sustained Effect Through 1 Year of Treatment in the PROMISE-1 Study. <i>Clinical therapeutics</i> 42(12) 2254–2265.e3. DOI:<a href=&quot;https://doi.org/10.1016/j.clinthera.2020.11.007&quot;>10.1016/j.clinthera.2020.11.007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33250209/&quot;>https://pubmed.ncbi.nlm.nih.gov/33250209</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Eptinezumab;
